At GFN 2023, SAB Diasmoke second meeting

GFN 2023 will start tomorrow at Varsavia. The 10th edition of the Global Forum on Nicotine, from 21 to 24 June, will host more events dedicated to harm reduction research. During this edition will be also the second meeting of SAB Diasmoke. Diabetologists and experts on THR signed the guidelines on the treatment of smokers with diabetes.

Continue ReadingAt GFN 2023, SAB Diasmoke second meeting

CoEHAR, UNIVERSITY OF CATANIA: HARM REDUCTION IS THE WEAPON TO DEFEAT SMOKE

“It is a fact that in Italy there are millions of smokers who are unwilling or unable to quit smoking – explained prof. Riccardo Polosa, founder of CoEHAR - These smokers do not accept to be medicalized because of their smoking habit and in Italy, even today, we do not have a health policy that takes care of these people. Risk reduction is the solution. In countries with a liberal approach, such as Sweden or England, which have chosen to open up to alternative nicotine release tools by promoting them in the cessation paths for heavy smokers, the prestigious smoke-free goal is being reached. It is time to follow these virtuous examples also in Italy".

Continue ReadingCoEHAR, UNIVERSITY OF CATANIA: HARM REDUCTION IS THE WEAPON TO DEFEAT SMOKE

CoEHAR researchers opposes study findings on pulmonary inflammation caused by vaping

According to Prof. Polosa: “The study does not present any causality between data and the hypothesis according to which there would be health complications for vapers”, In fact, as the scientist explains: “The very small sample size and low reproducibility of the tests does not allow us to give a precise and scientific answer on pulmonary inflammation caused by vaping because it does not take into consideration fundamental factors, such as the prior exposure to tobacco smoking”.

Continue ReadingCoEHAR researchers opposes study findings on pulmonary inflammation caused by vaping

CoEHAR researchers’ “guidebook”: how to identify data misinterpretations in ecig studies

Researchers from CoEHAR's In Silico Science project have developed a two-step technique to identify spin bias, research reporting that results in an intentional or unintentional misinterpretation of research results.

Continue ReadingCoEHAR researchers’ “guidebook”: how to identify data misinterpretations in ecig studies

Rome – Health, focus on “Global clinical risk: causes and intervention strategies”

One of the speakers of the event, moderated by Prof. Carla Bruschelli, was Prof. Riccardo Polosa, founder of CoEHAR, Center of Excellence for the acceleration of Harm Reduction, and professor of Internal Medicine at the University of Catania. The subject of his speech was the patient with COPD (Chronic Obstructive Pulmonary Disease) with addiction to smoking, which he defined as "a difficult patient, because he has a long history that has created a strong alliance with cigarettes. Therefore, giving up smoking leads him to a great form of distress, because it represents a loss”.

Continue ReadingRome – Health, focus on “Global clinical risk: causes and intervention strategies”

CEASEFIRE: first study in the world to assess the efficacy and safety of heated tobacco products and e-cig as a valid smoking cessation tool

“We observed an improvement in exercise tolerance in participants compared to the initial levels: many patients from the first month declared that they have more breath and to feel less fatigue in small but important daily activities such as climbing stairs or doing household” - added prof. Pasquale Caponnetto, professor of clinical psychology at DISFOR of the University of Catania and CoEHAR member.

Continue ReadingCEASEFIRE: first study in the world to assess the efficacy and safety of heated tobacco products and e-cig as a valid smoking cessation tool